4
Changes in Ownership
FENNEC PHARMACEUTICALS INC. Filed Acc 0001926254-26-000004
Chief Executive Officer acquired 31,797 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hackman Jeffrey S. Chief Executive Officer | 2026-03-31 | Option exercise | +16,695 | 45,405 | D | ||
| Hackman Jeffrey S. Chief Executive Officer | 2026-03-31 | Option exercise | +1,159 | 46,564 | D | ||
| Hackman Jeffrey S. Chief Executive Officer | 2026-03-28 | Option exercise | +13,943 | 60,507 | D | ||
| Derivatives | |||||||
| Hackman Jeffrey S. Chief Executive Officer | 2026-03-31 | Grant or award · Stock Options | +200,000 | $5.77 | $1,154,000 | 725,000 | D |
Loading xslF345X06/form4-04022026_040412.xml…